Autophagy as a Molecular Target of Flavonoids Underlying their Protective Effects in Human Disease
| Autor: | María Victoria García-Mediavilla, José L. Mauriz, Sonia Sánchez-Campos, Néstor Prieto-Domínguez, Javier González-Gallego |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
0301 basic medicine
Programmed cell death medicine.medical_treatment Cell Biochemistry 03 medical and health sciences In vivo Neoplasms Influenza Human Drug Discovery Autophagy Diabetes Mellitus medicine Humans Stomach Ulcer Leishmaniasis Cell Proliferation Flavonoids Pharmacology Cell growth business.industry Liver Diseases Organic Chemistry Cancer Neurodegenerative Diseases medicine.disease Asthma 030104 developmental biology medicine.anatomical_structure Cardiovascular Diseases Cancer research Osteoporosis Molecular Medicine business Adjuvant Homeostasis |
| Zdroj: | Current Medicinal Chemistry. 25:814-838 |
| ISSN: | 0929-8673 |
| DOI: | 10.2174/0929867324666170918125155 |
| Popis: | Background Autophagy is a cellular pathway with the ability to maintain cell homeostasis through the elimination of damaged or useless cellular components, and its deregulation may initiate or aggravate different human diseases. Flavonoids, a group of plant metabolites, are able to modulate different molecular and cellular processes including autophagy. Objective To review the effects of flavonoids on autophagy pathway in both invasive and noninvasive human diseases, focusing on the global outcomes in their progression. Moreover, the efficacy of the combination of flavonoids with drugs or other natural nontoxic compounds was also reviewed. Methods A literature search was performed to identify and analyze peer-reviewed publications containing in vitro and in vivo studies focused on autophagy deregulation in different proliferative and non-proliferative pathologies and the potential protective effects of flavonoids. Results Analyzed publications indicated that imbalance between cell death and survival induced by changes in autophagy play an important role in the pathophysiology of a number of human diseases. The use of different flavonoids as autophagy modulators, alone or in combination with other molecules, might be a worthy strategy in the treatment of cancer, neurodegenerative disorders, cardiovascular diseases, hepatic diseases, leishmaniasis, influenza, gastric ulcers produced by Helicobacter pylori infection, diabetes, asthma, age-related macular degeneration or osteoporosis. Conclusion Flavonoids could potentially constitute important adjuvant agents of conventional therapies in the treatment of autophagy deregulation-related diseases. Moreover, combined therapy may help to diminish the doses of those conventional treatments, leading to reduced drug-derivative side effects and to improved patients' survival. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|